Larvol Delta - A-Randomized-Phase-1-Evaluation-of-Deupirfenidone-a-Novel-DeuteriumContaining-Drug-Candidate-for-Interstitial-Lung-Disease-and-Other-Inflammatory-and-Fibrotic-Diseases

deuterium pirfenidone (LYT-100) - PureTech

http://www.ncbi.nlm.nih.gov/pubmed/34779583

Nov 17, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next